Share Name Share Symbol Market Type Share ISIN Share Description
Bioquell LSE:BQE London Ordinary Share GB0004992003 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 137.50p 135.00p 140.00p 137.50p 137.50p 137.50p 24,700.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 45.3 -1.4 -2.4 - 58.75

Bioquell Share Discussion Threads

Showing 1201 to 1223 of 1225 messages
Chat Pages: 49  48  47  46  45  44  43  42  41  40  39  38  Older
DateSubjectAuthorDiscuss
19/9/2016
12:24
some good points, especially on the market cap which will affect some of the other data quoted by advfn - I wonder how long it will take for this to be corrected
bountyhunter
19/9/2016
07:54
Couldn't resist a little punt here this morning.Got involved in BQE though the ST article and did well out of it but my initial involvement was simply based on the tender offer so sold out my second half at 145p when the sale of the remainder fell through. Read ST's follow up piece and got the the calculator out (please note I like to read ST but only seriously consider a very small percentage of his recommendations and always do my own thing. I would never dream of blaming someone who recommended a share if that turned out to be a poor choice, it was MY CHOICE.) BQE now looks very sound with: 1 new management 2 large and growing cash pile 3 very high Current Ratio of almost 4 4 EV/ EBITDA predicted to come in at a very low 6.5 NB ADVFN are giving the wrong market cap and it should be c. £30m not over £50m. My calculations are based on 23m shares so please check this out if you are interested.
pavey ark
24/8/2016
18:27
Interesting company this one. Bio- decontamination business continues to exhibit high margins but low profits and no revenue growth. Think the company has real potential but it's never really delivered. Valuation looks high at the moment, but will keep on the watch list. A buy at around a £1 with Chris Mills heavily invested I feel.
topvest
24/8/2016
11:48
I got out this morning fearing a big drop Happy to see what Simon Thompson has to say On the face of it a uk company aiming to be a world class leader should be just the Brexit ticket May return later
jbarcroftr
24/8/2016
11:27
well well no sale and CEO goes after doing stated fine job
ingroid
24/8/2016
09:47
Bioquell's EBITDA increased 14% to £1.6 million in the six months to the end of June and the group has now terminated its strategic review. Overall revenues declined by 3% to £12.1 million (2015: £12.5 million) but bio-decontamination revenues (excluding defence sales) rose by 8% to £11.1 million (2015: £10.3 million) and non-UK revenues amounted to £9.0 million (2015: £10.0 million) - representing 74% of total revenues. Gross margin increased to 46% (2015: 42%). Earnings per share were 0.8p (2015: 82.5p, 0.2p excluding the profit on disposal of TRaC). Following the completion of the June tender offer, £40.8 million of cash was returned to shareholders via a share buyback, leaving net cash of £7.3 million at 30 June, 2016 (2015: £47.7 million). Chairman Ian Johnson said: "Whilst overall revenues declined slightly as a result of lower defence sales compared with the first half of 2015, I am pleased to report that our bio-decontamination business grew by 8%. "Profitability improved as a result of our cost reduction programme - and management continues to seek further improvements in the financial performance of the business through greater focus on the international Life Sciences market and driving up the proportion of recurring revenues. "The board has now concluded the strategic review announced in 2015 and believes that Bioquell shareholders' interests would best be served by continuing to build a world class bio-decontamination business and focusing on further improving its financial performance. "Accordingly the management of the business will be restructured. I have become Executive Chairman and the current Chief Executive, Nick Adams, has stepped down. In addition, Jay LeCoque has joined the board of Bioquell in the new role of Commercial Director. "On behalf of all Bioquell shareholders I would like to thank Nigel Keen for his seven years as chairman. "I would also like to thank Nick Adams for his substantial contribution as chief executive. Under his leadership Bioquell has changed beyond all recognition from a low technology manufacturer of safety cabinets to a leader in specialist bio-decontamination. "The board is confident that the improved financial performance seen in the first half of the year will carry through to the full year." At 8:17am: (LON:BQE) Bioquell PLC share price was -8p at 145.5p
bangalorebob
09/8/2016
17:37
and now 3.99% http://uk.advfn.com/stock-market/london/bioquell-BQE/share-news/Martin-MacLeish-Form-8-3-Bioquell-PLC/72174506
bountyhunter
05/8/2016
17:17
and now 3.73% Http://uk.advfn.com/stock-market/london/bioquell-BQE/share-news/Martin-MacLeish-Form-8-3-Bioquell-PLC/72152424
bountyhunter
04/8/2016
17:08
Martin MAcleish is still accumulating, it's 3.47% now... http://uk.advfn.com/stock-market/london/bioquell-BQE/share-news/Martin-MacLeish-Form-8-3-Bioquell-PLC/72141188
bountyhunter
04/8/2016
15:10
yes that 80% of sales overseas is something I have had in mind while holding on here
bountyhunter
04/8/2016
14:46
” (BQE) generates 80 per cent of its sales overseas, something worth bearing in mind considering the company is up for sale and in bid talks." From an update in IC 11th July. "in bid talks" !!!??.......how long can this go on ? Fifteen months to sell the company....time to sell or get on with building up the remainder of the company into a position where it can be sold.
pavey ark
04/8/2016
14:06
lots of buys accumulating to 3.28% Http://uk.advfn.com/stock-market/london/bioquell-BQE/share-news/Martin-MacLeish-Form-8-3-Bioquell-PLC/72139609
bountyhunter
03/7/2016
14:53
PA, Yes received the cash on Friday with idealing.
cockerhoop
03/7/2016
12:21
Thanks PA that's helpful. I agree that the sale process may stall for a while in the face of the current uncertainty. Yes finally (after some confusion!) to the last part. Cheers, bh
bountyhunter
03/7/2016
08:58
Bountyhunter, detailed geographical breakdown in the results. C.£7m out of £26m. My understanding is that things are not very straightforward regarding the non EU exports as these would be covered by the existing trade agreement with these countries and the EU. The existing trade agreements remain until a final settlement is concluded but much bobbing,weaving,ducking and diving to be done before that. None of the above matters to Bioquell holders if the company is sold but I can't think that this uncertainty will speed up the sale process. One thought is that the fall in the value of the £ makes it more attractive to a foreign buyer. (Do other people have the cash in their accounts yet ?)
pavey ark
02/7/2016
20:41
Anyone know offhand what proportion of Bioquell's sales are to the EU?
bountyhunter
27/6/2016
09:10
I like being able to phone as well as trade online for the same price and they're always happy to contact the MM's if i'm trying to get well inside the spread on something illiquid. They offer DMA as well. I do maintain a Crest sponsored account in addition, previously with Stocktrade now with Charles Stanley which allows easy attendance of AGM's etc as on the share register but find idealing more flexible, easier to trade at better prices.
cockerhoop
27/6/2016
08:47
PA, Idealing updated my account last Wednesday, They've generally been very quick in updating the tender information and resultant share holding but occasionally have been tardy in funding the account with the proceeds from the corporate actions. I have had a few tender offers on holdings over the last 18 months and have generally been happy with the service.
cockerhoop
27/6/2016
08:27
My share account is still blocked with no indication of shares sold in the tender. I have no intention of selling my remaining shares but this could be the push required to change my broker. I have other accounts with a different broker but all my BQE shares are with Alliance Trust. (I'm a bit slow to act here because the Corporate Actions dept were very good about a problem with the tendering of shares I held for a third party but I have noted that Alliance Trust are increasing their charges and wonder if the service is good enough) Do other people have this tender information ?
pavey ark
22/6/2016
12:37
I read Simon Thompson's articles in the IC but I didn't know that he follows my posts here. Joking aside ST has just updated his coverage of BQE and is even more upbeat than me but to be fair he does have a bit of an inside track at times. Long and short of fairly lengthy update is that he recommends that you take your cash from the share buy-back and buy more shares.
pavey ark
22/6/2016
10:04
To clarify individual brokers will only get 50% of the total holding of it's customers but say a broker has 10 nominee investors with equal holdings in BQE, 9 opt to tender 100% and the 10th is away holiday or forgot to tender. Because the brokers 50% allocation is covered by the 9 wanting 100% the 10th's allocation is shared amongst the 9.
cockerhoop
22/6/2016
09:36
It is somewhat weird that individual brokers can put in place arrangements to tender what other clients don't. But that's what happened to me and that probably explains the 47% take-up as I'd normally expect the "no shows" to be 5-10%.
18bt
22/6/2016
09:13
I have asked my broker to clarify exactly how many shares I was able to get through too as my entire holding is still blocked. Does anyone have any idea when it will all be complete?
hornets89
Chat Pages: 49  48  47  46  45  44  43  42  41  40  39  38  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20161211 06:08:27